Hepatocellular Carcinoma and Hepatotoxicity
Natalyia Razumilava, MD, discusses the risks and testing for hepatocellular carcinoma (HCC), how many are meeting the Milan criteria at the time of diagnosis, the impact of a structured HCC surveillance program on outcomes and the newer GALADUS score for HCC diagnosis. She also addresses hepatotoxicity, herbal and dietary supplement induced liver injury and the leading causes of drug-induced liver injury (DILI) in children. Presented at the U-M 20th Annual Liver Disease Wrap Up CME. Learn more about liver disease and hepatology services at Michigan Medicine: https://www.uofmhealth.org/conditions...
▶︎
Genomics and Cancer Biomarkers for HCC: Potential Applications
▶︎
Approach to drug induced liver injury and cell mediated hepatitis | UCLA Digestive Diseases
▶︎
Can a keto diet eliminate cancer growth? Dr. Thomas Seyfried says yes
▶︎
Advanced Liver Disease Case Discussions
▶︎
Bladder Cancer Explained: Risk Factors, Symptoms & Treatment
▶︎
WEBINAR: Cancer-Induced Peripheral Neuropathy: How to Manage Symptoms
▶︎
Hiatal Hernia: 4 Hidden Symptoms
▶︎
Liver Cancer (Hepatocellular Carcinoma) Signs & Symptoms (Why They Occur & Metastases)
▶︎
Cirrhosis and Portal Hypertension
▶︎
Liver Function Tests (LFTs) | Clinical Medicine
▶︎
Your Doctor Is Wrong About Cholesterol
▶︎
The Silent Signs Of Breast Cancer
▶︎
Fighting Hepatocellular Carcinoma: Key Facts
▶︎
7 Sintomas ng Hepatitis B at Liver Disease. By Doc Willie Ong
▶︎
I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.
▶︎
Kidney Cancer / Renal Cell Carcinoma: EXPLAINED
▶︎
Hepatocellular Carcinoma - Molecular Approaches to Treatment
▶︎
Progression of Liver Disease Webcast Series: Cirrhosis and Signs of Liver Failure
▶︎
Renal Replacement Therapy/Dialysis Advanced - Type of CRRT (CVVH, CVVHD, CVVHDF) | Clinical Medicine
▶︎